Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glycemicon AG

www.glycemicon.com

Latest From Glycemicon AG

Looking For The New Lantus: Next-Gen Diabetes Hopefuls Defy Risks

The diabetes market presents competitive, commercial, and regulatory challenges, but its size and breadth spur emerging biotechs to develop an ever-wider range of treatments and technologies.

BioPharmaceutical Clinical Trials

Out Of The Blocks, January 2014

Highlighting these recently formed companies: Abeona Therapeutics, Acera Surgical, Glycemicon, InPress Technologies, and Madison Vaccines.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Glycemicon AG
  • Senior Management
  • Susanne Wolfrum, PhD, CSO
    Nadja Mrosek, MD, COO
  • Contact Info
  • Glycemicon AG
    Phone: 44 655 7231
    Schorenstrasse 16, c/o ETH Zürich, IFNH
    Schwerzenbach, 8603
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register